HDL Therapeutics
Vero Beach, US · Founded 2013
Biotech
Founders & leadership
BB
Bryan BrewerDr. Brewer is the Chief Scientific Officer of the Issuer.
MM
Michael MatinExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$1.3MraisedJul 2023 · 15 investors · Biotechnology
Rule 506(b)$3.4MraisedMar 2021 · 31 investors · Biotechnology
Rule 506(b)$3MraisedOct 2019 · 34 investors · Biotechnology
Rule 506(b)$7.2MraisedMay 2017 · 57 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.